Bayer and Arvinas to Collaborate on Human PROTAC Therapies and Launch a Separate Joint Venture to Develop Agricultural PROTAC Applications Read more
Celgene and Acceleron Announce FDA Accepts Luspatercept Biologics License Application in Myelodysplastic Syndromes and Beta-Thalassemia Read more
Vertex Expands into New Disease Areas and Enhances Gene Editing Capabilities Through Expanded Collaboration with CRISPR Therapeutics and Acquisition of Exonics Therapeutics Read more
Innovation Pharma Signs Agreement for Advanced Oral Tablet Technology in Treating Inflammatory Bowel Disease Read more
Servier appoints Yposkesi for lentiviral vector GMP-manufacturing in CAR-T cell development technology Read more